23andMe Holding Co. (MEHCQ)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	38.25	216.49	386.85	553.18	282.49
Cash & Short-Term Investments	38.25	216.49	386.85	553.18	282.49
Cash Growth	-82.33%	-44.04%	-30.07%	95.82%	35.85%
Accounts Receivable	1.35	3.32	1.9	3.38	2.48
Other Receivables	19.88	5.75	3	-	-
Receivables	21.23	9.08	4.9	3.38	2.48
Inventory	15.56	12.47	10.25	10.79	6.24
Prepaid Expenses	8.83	7.9	13.24	24.44	15.49
Restricted Cash	7.75	1.4	1.4	1.6	1.4
Other Current Assets	11.1	7.99	8.35	8.4	5.48
Total Current Assets	102.71	255.31	424.99	601.79	313.58
Property, Plant & Equipment	1.79	59.78	93.83	104.58	123.15
Goodwill	-	-	351.74	351.74	-
Other Intangible Assets	44.73	53.77	61.18	83.54	6.89
Other Long-Term Assets	10.67	26.31	10.85	10.42	8.48
Total Assets	159.89	395.17	942.6	1,152	452.1
Accounts Payable	0.55	5.37	12.92	37.93	12.27
Accrued Expenses	15.07	29.72	65.07	42.55	31.62
Current Portion of Leases	7.31	4.93	7.54	7.78	6.14
Current Income Taxes Payable	0.43	1.11	1.36	2.04	0.34
Current Unearned Revenue	49.35	64.83	62.52	62.94	71.26
Other Current Liabilities	-	21.37	-	-	-
Total Current Liabilities	72.7	127.33	149.42	153.24	121.62
Long-Term Leases	0.21	59.84	77.76	78.52	87.58
Long-Term Unearned Revenue	-	10	-	-	-
Other Long-Term Liabilities	113.73	9.48	1.48	4.65	1.17
Total Liabilities	186.64	206.65	228.66	236.41	210.37
Common Stock	0	0	0.05	0.05	0.01
Additional Paid-In Capital	2,427	2,362	2,221	2,110	381.61
Retained Earnings	-2,454	-2,173	-1,506	-1,195	-977.24
Comprehensive Income & Other	-	-	-0.62	0.18	-
Total Common Equity	-26.74	188.52	713.94	915.66	-595.62
Shareholders' Equity	-26.74	188.52	713.94	915.66	241.73
Total Liabilities & Equity	159.89	395.17	942.6	1,152	452.1
Total Debt	7.51	64.77	85.3	86.31	93.72
Net Cash (Debt)	30.74	151.72	301.55	466.87	188.77
Net Cash Growth	-79.74%	-49.69%	-35.41%	147.33%	60.49%
Net Cash Per Share	1.19	6.38	13.36	25.83	37.88
Filing Date Shares Outstanding	27.54	24.51	23.06	22.46	20.32
Total Common Shares Outstanding	27.44	24.51	23.06	22.44	54.29
Working Capital	30	127.98	275.58	448.55	191.96
Book Value Per Share	-0.97	7.69	30.96	40.80	-10.97
Tangible Book Value	-71.47	134.75	301.01	480.37	-602.51
Tangible Book Value Per Share	-2.60	5.50	13.05	21.41	-11.10
Machinery	38.23	49.3	72.11	71.06	70.69
Leasehold Improvements	0.97	31.25	40.96	40.57	39.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.